An unusual case of diabetes
When her usual GP is on leave, 67-year-old Jen presents to a GP she has not seen previously with early cellulitis affecting her forearm, after…
Tag: Endocrinology – Diabetes
‘Another burden’: RACGP rejects proposed PBS restrictions on diabetes drugs
The RACGP has rejected calls for the PBS listing for initiating GLP-1 receptor agonists to move to authority required amid concerns it will add to…
Diabetes onset before age 60 triples dementia risk, study shows
Patients diagnosed with type 2 diabetes before they turn 60 are nearly three times more likely to develop dementia than those without incident diabetes, shows…
Endometriosis a ‘red flag’ for GDM, review shows
Women with severe endometriosis are three times more likely to develop gestational diabetes than those with milder forms of the condition, according to a systematic…
Diabetes screening in women with prior GDM ‘suboptimal’
One in three Australian women with prior gestational diabetes miss out on postpartum screening for type 2 diabetes, shows an analysis of primary care data.…
GDM treatment before 20 weeks cuts risk of adverse neonatal events: Aus study
Treating gestational diabetes before 20 weeks cuts the risk of neonatal respiratory distress by a fifth compared with intervention later in pregnancy, Australian doctors report. …
Why sign the petition against the pharmacist prescribing trial? This is how they’ll manage CV risk in T2DM
The opposition to the North Queensland trial is simple. It is about the clinical safety of community pharmacists diagnosing, prescribing, managing and dispensing well beyond…
Giant blisters a rare complication of diabetes: case
Dermatologists are reporting a rare case of spontaneous blistering on the toes, dorsal foot surface and ankle of a patient with type 2 diabetes in…
Companies that spruik online weight loss drug prescriptions in TGA’s sights
Websites advertising prescriptions for weight loss drugs via an online quiz are on the TGA’s radar for advertising medications through social media and online ads. …
PBS delisting triggers govt intervention on diabetes drug
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
